Your browser is no longer supported. Please, upgrade your browser.
NVTA Invitae Corporation daily Stock Chart
Invitae Corporation
Index- P/E- EPS (ttm)-1.42 Insider Own1.10% Shs Outstand71.18M Perf Week15.62%
Market Cap1.14B Forward P/E- EPS next Y-1.44 Insider Trans-3.39% Shs Float70.22M Perf Month12.31%
Income-91.20M PEG- EPS next Q-0.45 Inst Own76.80% Short Float8.05% Perf Quarter31.21%
Sales127.70M P/S8.95 EPS this Y46.90% Inst Trans0.22% Short Ratio4.98 Perf Half Y54.72%
Book/sh2.56 P/B6.27 EPS next Y26.90% ROA-59.40% Target Price18.13 Perf Year160.71%
Cash/sh1.82 P/C8.85 EPS next 5Y8.00% ROE-103.40% 52W Range4.35 - 18.38 Perf YTD45.21%
Dividend- P/FCF- EPS past 5Y-39.60% ROI-42.50% 52W High-12.60% Beta2.05
Dividend %- Quick Ratio3.90 Sales past 5Y- Gross Margin40.50% 52W Low269.20% ATR0.87
Employees723 Current Ratio3.90 Sales Q/Q106.60% Oper. Margin- RSI (14)69.38 Volatility7.26% 5.80%
OptionableYes Debt/Eq0.35 EPS Q/Q20.40% Profit Margin- Rel Volume1.28 Prev Close15.94
ShortableYes LT Debt/Eq0.29 EarningsFeb 19 AMC Payout- Avg Volume1.13M Price16.06
Recom1.70 SMA2012.65% SMA5023.50% SMA20041.25% Volume1,452,948 Change0.75%
Dec-19-18Initiated Oppenheimer Outperform
Nov-20-18Resumed The Benchmark Company Buy $17
Feb-13-18Reiterated The Benchmark Company Buy $11 → $10
Jan-16-18Reiterated The Benchmark Company Buy $16 → $11
Jan-16-18Reiterated Leerink Partners Outperform $12 → $10
Jan-05-18Initiated Ladenburg Thalmann Buy $15
Apr-03-17Reiterated The Benchmark Company Buy $11 → $16
Feb-14-17Upgrade The Benchmark Company Hold → Buy $8.50 → $11
Nov-10-16Resumed Leerink Partners Outperform
Jun-30-16Initiated The Benchmark Company Hold $8.50
Jan-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-14-15Initiated William Blair Mkt Perform
May-14-15Upgrade Leerink Partners Mkt Perform → Outperform
Feb-13-19 04:06PM  5 Top Stock Trades for Thursday: NVTA, MU, NVDA, AAPL, TWLO InvestorPlace +7.56%
07:45AM  Recent Analysis Shows General Mills, Paycom Software, Invitae, Jagged Peak Energy, John B. Sanfilippo & Son, and Intrepid Potash Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
07:30AM  Invitae to Present at the 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-12-19 10:30AM  Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
08:48AM  Is the Options Market Predicting a Spike in Invitae (NVTA) Stock? Zacks
07:30AM  Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information in Early Pregnancy PR Newswire
Feb-08-19 10:33PM  Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January Motley Fool
10:40AM  4 Disruptive Healthcare Stocks You've Never Heard Of Motley Fool
Feb-07-19 02:52PM  How Many Insiders Sold Invitae Corporation (NYSE:NVTA) Shares? Simply Wall St.
12:00PM  New Study Finds Disease-Causing Variants More Common in Men with Prostate Cancer Than Previously Thought PR Newswire
Feb-03-19 10:19AM  3 Top Stocks That Aren't on Wall Street's Radar Motley Fool
Jan-29-19 07:30AM  Invitae to announce fourth quarter and year-end 2018 financial results on February 19, 2019 PR Newswire
Jan-07-19 11:23AM  Here's Why Invitae Gained as Much as 16% Today Motley Fool +16.44%
07:30AM  Invitae reports 2018 preliminary financial results, delivering more than 100% volume and revenue growth in 2018; projects sustained growth in expanding markets through 2019 and beyond PR Newswire
Dec-27-18 12:27PM  3 Gene Therapy Stocks to Play Biotechs Future InvestorPlace
Dec-20-18 04:31PM  Invitae to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire -9.11%
Dec-15-18 10:45AM  Do Hedge Funds Love InVitae Corporation (NVTA)? Insider Monkey
Dec-12-18 09:06AM  Here Are 3 Small-Cap Names for Biotech Investors to Consider
Dec-10-18 07:30AM  New Study Published in Journal of Clinical Oncology Supports Universal Genetic Testing for all Breast Cancer Patients PR Newswire
Dec-06-18 05:00AM  Invitae- The Second Time Around MoneyShow
Dec-04-18 08:15AM  Detailed Research: Economic Perspectives on United Technologies, Walmart, Invitae, Emergent Biosolutions, U.S. Physical Therapy, and Amdocs What Drives Growth in Today's Competitive Landscape GlobeNewswire -8.64%
Nov-16-18 04:54PM  This High-Growth Biotech Industry Is as Competitive as Ever Heading Into 2019 Motley Fool
Nov-14-18 03:27PM  Edited Transcript of NVTA earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
07:30AM  Invitae Highlighting New Research, Honoring Excellence in Genetic Counseling at National Society of Genetic Counselors (NSGC) 37th Annual Conference PR Newswire
Nov-13-18 02:48PM  It May Be Time to Buy Invitae -7.83%
Nov-08-18 03:15PM  Why Invitae Corporation Is Tanking Today Motley Fool -11.27%
Nov-07-18 08:26PM  Here's Why Invitae Lost 15.2% in October Motley Fool
06:50PM  Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:44PM  Invitae: 3Q Earnings Snapshot Associated Press
04:05PM  Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume in Third Quarter 2018 PR Newswire
Oct-31-18 10:32AM  Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks +7.18%
Oct-29-18 07:30AM  Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria PR Newswire
Oct-25-18 08:30AM  Report: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +6.46%
Oct-24-18 07:30AM  Invitae to announce third quarter 2018 financial results on November 7, 2018 PR Newswire -6.00%
Oct-17-18 07:30AM  Research shows high positive rate for risk of hereditary disease in study of proactive genetic health screening for healthy people PR Newswire
Oct-11-18 07:18AM  Here's Why Invitae Jumped 13% in September Motley Fool
Sep-20-18 10:03AM  Is Invitae Corporation (NYSE:NVTA) Still A Cheap Healthcare Stock? Simply Wall St.
Sep-18-18 07:30AM  Invitae to Present at the Ladenburg Thalmann 2018 Healthcare Conference PR Newswire +10.84%
Sep-11-18 07:30AM  Invitae Appoints Chitra Nayak to its Board of Directors PR Newswire
Sep-07-18 08:44AM  Implied Volatility Surging for Invitae (NVTA) Stock Options Zacks
Sep-05-18 07:40AM  Factors of Influence in 2018, Key Indicators and Opportunity within Destination XL Group, Invitae, Federated National Holding, Bridge, QCR, and Kelly Services New Research Emphasizes Economic Growth GlobeNewswire
12:58AM  Here's Why Invitae Rose 67.5% in August Motley Fool
Aug-19-18 09:35PM  Edited Transcript of NVTA earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-16-18 08:15AM  Investor Expectations to Drive Momentum within Global Medical REIT, Cyclacel Pharmaceuticals, Super Micro Computer, Kelly Services, Invitae, and ScanSource Discovering Underlying Factors of Influence GlobeNewswire
Aug-08-18 11:40AM  Here's Why Invitae Corp Rose as Much as 20.6% Today Motley Fool +17.41%
Aug-07-18 06:50PM  Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:45PM  Invitae: 2Q Earnings Snapshot Associated Press
04:05PM  Invitae Reports More than 160% Annual Revenue Growth Driven by Nearly 140% Annual Growth in Volume in Second Quarter 2018 PR Newswire
02:30PM  Invitae Corp. to Host Earnings Call ACCESSWIRE
Aug-06-18 08:48AM  Cerner (CERN) Looks Good: Stock Adds 6.2% in Session Zacks
Jul-26-18 06:34AM  Invitae (NVTA): Moving Average Crossover Alert Zacks
Jul-24-18 07:30AM  Invitae to announce second quarter 2018 Financial Results on August 7, 2018 PR Newswire
Jul-16-18 07:20AM  Free Stock Performance Review on IQVIA Holdings and Three Additional Medical Research Stocks ACCESSWIRE
Jul-06-18 06:40AM  Here's Why Invitae Dropped 14.9% in 2018 (So Far) Motley Fool
Jun-25-18 07:30AM  Invitae Expands Reproductive Health Offering with Launch of Comprehensive Genetic Carrier Screening PR Newswire -7.30%
Jun-13-18 07:30AM  Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing PR Newswire
Jun-04-18 07:10AM  Stock Performance Review on Exact Sciences and Three Other Medical Research Stocks ACCESSWIRE
May-30-18 07:30AM  Invitae to Present at the William Blair 2018 Growth Stock Conference PR Newswire
May-17-18 05:05PM  Why This Genetics Stock Could Be a Gold Mine for Growth Investors Motley Fool
May-15-18 07:52AM  Edited Transcript of NVTA earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-10-18 01:30PM  Here's Why Invitae Rose as Much as 13.9% Today Motley Fool +10.98%
May-09-18 05:19PM  Invitae: 1Q Earnings Snapshot Associated Press +5.71%
04:05PM  Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018 PR Newswire
07:11AM  The Zacks Analyst Blog Highlights: Audiocodes, Farmland Partners, Invitae, Global Medical and Glu Zacks
May-08-18 03:28PM  5 of the Best Stocks Under $10 for 2018 Zacks
09:44AM featured highlights include: Del Taco, WellCare Health, Invitae, Visteon and Toll Brothers Zacks
May-07-18 08:16AM  Play Stocks With Rising P/E to Enjoy Solid Gains Zacks +5.82%
07:30AM  Sarepta and Invitae Expand Partnership to Advance Clinical Research in Duchenne Muscular Dystrophy PR Newswire
May-04-18 07:55AM  Market Trends Toward New Normal in LRAD, Xencor, QuinStreet, Old Second, WesBanco, and Invitae Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
May-03-18 07:30AM  Invitae to participate in two upcoming investor conferences, the Bank of America Merrill Lynch 2018 Heath Care Conference and the UBS Global Healthcare Conference PR Newswire
Apr-27-18 07:30AM  Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA) PR Newswire
Apr-25-18 07:30AM  Invitae to Announce First Quarter 2018 Financial Results on May 9, 2018 PR Newswire
Mar-28-18 12:07PM  Here's Why Invitae Stock Dropped as Much as 19.6% Today Motley Fool -13.12%
06:00AM  Invitae Announces Pricing of Public Offering of Common Stock PR Newswire
Mar-27-18 11:56AM  This Explains Why Invitae Is Sinking Today Motley Fool -22.71%
09:48AM  Invitae Corporation (NYSE:NVTA): When Will It Breakeven? Simply Wall St.
Mar-26-18 05:13PM  9 Stocks Moving In Monday's After-Hours Session Benzinga
04:05PM  Invitae Announces Proposed Public Offering of Common Stock PR Newswire
Mar-22-18 07:30AM  Invitae expands network of patients in rare and ultra-rare diseases PR Newswire
Mar-19-18 08:00AM  Analysis: Positioning to Benefit within ICF International, Invitae, Encore Wire, Alexandria Real Estate Equities, Syndax Pharmaceuticals, and Vical Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-16-18 07:30AM  Invitae partners with KEW, Inc. to develop somatic mutation detection capabilities to improve cancer care by providing comprehensive genomic information PR Newswire
Mar-06-18 01:39PM  What Are Analysts Saying About Invitae Corporations (NYSE:NVTA) Future? Simply Wall St.
Feb-27-18 04:05PM  Invitae expands existing credit facility to provide up to $40.0 million in available growth capital PR Newswire
Feb-26-18 07:30AM  Invitae to present at the Cowen and Company 38th Annual Health Care Conference PR Newswire
Feb-23-18 07:56AM  3 Top Small-Cap Stocks to Buy in February Motley Fool
Feb-15-18 11:02AM  Best-In-Class Growth Stocks Simply Wall St.
Feb-13-18 12:41PM  Here's Why Invitae Dropped as Much as 18.3% Today Motley Fool
10:03AM  Edited Transcript of NVTA earnings conference call or presentation 12-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-12-18 04:57PM  Invitae reports 4Q loss Associated Press
12:00PM  Invitae Corp. to Host Earnings Call ACCESSWIRE
09:36AM  With A -7.99% Earnings Drop Lately, Did Invitae Corporation (NYSE:NVTA) Underperform Its Industry? Simply Wall St.
Jan-31-18 07:30AM  Invitae to participate in two upcoming investor conferences, including the 2018 BIO CEO & Investor Conference and Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
Jan-29-18 07:30AM  Invitae to announce fourth quarter and year-end 2017 financial results on February 12, 2018 PR Newswire
Jan-17-18 06:33AM  3 Stocks That Could Double in the Next Decade Motley Fool -6.75%
Jan-09-18 07:45AM  Report: Exploring Fundamental Drivers Behind Invitae, MKS Instruments, YRC Worldwide, Hospitality Properties, Pioneer Energy Services, and Encore Wire New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +6.37%
Jan-08-18 03:03PM  Here's Why Invitae Dropped as Much as 14.3% Today Motley Fool -14.13%
07:30AM  Invitae more than doubles annual volume, exceeds full-year 2017 guidance, and projects momentum to continue in 2018 PR Newswire
Jan-02-18 09:07PM  My 3 Top Growth Stocks for 2018 Motley Fool
11:12AM  ETFs with exposure to Invitae Corp. : January 2, 2018 Capital Cube
Dec-26-17 11:02AM  Best AMEX Growth Stocks Simply Wall St.
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; proactive health and wellness screening; and preimplantation embryo testing and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It also operates Patient Insights Networks, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform that is used for the collection, analysis, and management of patient family history information. Invitae Corporation serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dumond PattySee RemarksJan 16Sale15.003,00045,00093,811Jan 18 05:37 PM
Guyer Shelly DChief Financial OfficerJan 16Sale14.494,00057,968160,865Jan 18 05:34 PM
Stueland KatherineChief Commercial OfficerJan 15Sale13.591,00013,590188,370Jan 16 04:39 PM
Nussbaum Robert LChief Medical OfficerJan 10Sale14.015,22273,153163,769Jan 14 09:13 PM
Stueland KatherineChief Commercial OfficerDec 17Sale11.441,00011,437189,370Dec 19 08:08 PM
AGUIAR ERICDirectorNov 27Sale13.5010,000135,0000Nov 28 07:17 PM
Dumond PattySee RemarksNov 16Sale12.902,00025,80096,811Nov 20 07:46 PM
Dumond PattySee RemarksSep 20Sale16.513555,86198,811Sep 20 07:00 PM
Dumond PattySee RemarksSep 18Sale16.672904,83499,166Sep 20 07:00 PM
Stueland KatherineChief Commercial OfficerSep 09Sale13.625958,104191,963Sep 11 08:55 PM
Nussbaum Robert LChief Medical OfficerMay 15Sale6.966,70246,64654,435May 16 09:06 PM
Dumond PattySee RemarksMay 15Sale6.965,01434,89754,456May 16 08:40 PM
Guyer Shelly DChief Financial OfficerMay 15Sale6.965,13535,74039,865May 16 09:11 PM
George Sean EPresident & CEOMay 15Sale6.9620,311141,365409,289May 16 09:07 PM
Brida ThomasGeneral CounselMay 15Sale6.961,97913,77425,973May 16 08:48 PM
BENDEKGEY E LEEChief Operating OfficerMay 15Sale6.966,38844,46052,396May 16 09:02 PM
Stueland KatherineChief Commercial OfficerMay 15Sale6.966,01241,84452,558May 16 08:42 PM
Scott Randal WExecutive ChairmanApr 02Buy4.5044,444199,9983,550,669Apr 02 04:05 PM
BAKER BROS. ADVISORS LP10% OwnerMar 28Buy4.501,111,1115,000,0007,480,182Mar 29 03:59 PM